{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:05:10Z","timestamp":1780473910650,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacl.2025.09.018","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:47:52Z","timestamp":1758602872000},"page":"1657-1667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Noninvasive indices of hepatic steatosis and fibrosis for the prediction of obstructive coronary artery disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Dimitrios","family":"Trygoniaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3061-7864","authenticated-orcid":false,"given":"Nikolaos","family":"Mittas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-8121","authenticated-orcid":false,"given":"Andreas S.","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-5942","authenticated-orcid":false,"given":"Efstratios","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fani","family":"Chatzopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Chatzidimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefteris","family":"Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis S.","family":"Vizirianakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.09.018_bib0001","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2025.09.018_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jacl.2025.09.018_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.934225","article-title":"Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: a meta-analysis","volume":"13","author":"Wen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacl.2025.09.018_bib0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/apt.16575","article-title":"Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations","volume":"54","author":"Polyzos","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacl.2025.09.018_bib0006","doi-asserted-by":"crossref","first-page":"344","DOI":"10.31083\/j.rcm2509344","article-title":"Non-invasive serum markers of Non-alcoholic fatty liver disease fibrosis: potential tools for detecting patients with cardiovascular disease","volume":"25","author":"Chen","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacl.2025.09.018_bib0007","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2017.12.012","article-title":"Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study","volume":"68","author":"Lee","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0008","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gutjnl-2022-327672","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals","volume":"72","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jacl.2025.09.018_bib0009","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2021.05.008","article-title":"Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease","volume":"75","author":"Younes","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.09.018_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijcard.2018.05.087","article-title":"The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe","volume":"270","author":"Simon","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0012","first-page":"218","article-title":"Non-invasive assessment of liver fibrosis","volume":"25","author":"Papastergiou","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0013","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Barton Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.09.018_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155666","article-title":"Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: results from a large multi-center study","volume":"147","author":"Kouvari","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2025.09.018_bib0016","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2025.09.018_bib0017","first-page":"1","article-title":"The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease\u2014Rationale and design of the GESS study","volume":"21","author":"Vizirianakis","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacl.2025.09.018_bib0018","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jacl.2025.09.018_bib0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.jacl.2025.09.018_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2307\/2529204","article-title":"A cluster analysis method for grouping means in the analysis of variance","volume":"30","author":"Scott","year":"1974","journal-title":"Biometrics"},{"key":"10.1016\/j.jacl.2025.09.018_bib0021","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s12350-011-9425-5","article-title":"Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events","volume":"18","author":"Versteylen","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.09.018_bib0023","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.09.018_bib0024","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"9","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jacl.2025.09.018_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/life12081189","article-title":"New insights into non-alcoholic fatty liver disease and coronary artery disease: the liver-heart axis","volume":"12","author":"Cazac","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.jacl.2025.09.018_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.711484","article-title":"Nonalcoholic fatty liver disease, liver fibrosis and cardiovascular disease in the adult US population","volume":"12","author":"Ciardullo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacl.2025.09.018_bib0028","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/clinem\/dgae619","article-title":"Incremental value of blood-based markers of liver fibrosis in cardiovascular risk stratification","volume":"110","author":"Georgiopoulos","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2025.09.018_bib0029","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12072-021-10167-w","article-title":"Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease","volume":"15","author":"Jin","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jacl.2025.09.018_bib0030","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/ehf2.14336","article-title":"Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction","volume":"10","author":"Cao","year":"2023","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.jacl.2025.09.018_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018869","article-title":"Liver fibrosis scoring systems as novel tools for predicting cardiovascular outcomes in patients following elective percutaneous coronary intervention","volume":"10","author":"Liu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2025.09.018_bib0032","first-page":"1","article-title":"Comparative evaluation of non-invasive tests for risk stratification for cause specific mortality in at-risk population of hepatic fibrosis","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2025.09.018_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266965","article-title":"Systematic screening for advanced liver fibrosis in patients with coronary artery disease: the CORONASH study","volume":"17","author":"Th\u00e9venot","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2025.09.018_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01081-w","article-title":"Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: the progression of AtheRosclerotic PlAque DetermIned by computed TomoGraphic angiography IMaging (PARADIGM) registry","volume":"19","author":"Won","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12933-023-01906-4","article-title":"Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis","volume":"22","author":"Liang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0036","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0037","article-title":"Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in Cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2025.09.018_bib0038","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.cgh.2023.04.026","article-title":"Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population","volume":"21","author":"Seo","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2025.09.018_bib0039","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/dom.16117","article-title":"Hepatic thyroid hormone receptor-\u03b2 signalling: mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis","volume":"27","author":"Polyzos","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacl.2025.09.018_bib0040","article-title":"Triglyceride-glucose index and major adverse cardiovascular events in diabetic and nondiabetic patients: A systematic review and meta-analysis","volume":"1","author":"Mousavi","year":"2025","journal-title":"Diabetes Technol Obes Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425004040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425004040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:37:18Z","timestamp":1780472238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425004040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1933287425004040"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.09.018","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive indices of hepatic steatosis and fibrosis for the prediction of obstructive coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}